B

BiohacksAI

Evidence-Based Biohacking

Patent Pending

Bremelanotide

a synthetic peptide analogue of alpha-MSH, is an agonist at melanocortin receptors including the MC3R and MC4R, which are expressed primarily in the central nervous system;

36 PubMed studies analyzed · 14 RCTs · Evidence Score: 54.1

Research Domains

Bremelanotide has been studied across 10 research domains including 😴 Sleep, ♀♂ Sexual Health, 🧬 Hormones, 🧠 Focus & Attention, ❤️ Cardiovascular. The primary research focus is 😴 Sleep with 86% of studies addressing this area.

Loading evidence profile...

This evidence profile for Bremelanotide is generated deterministically from 36 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.